Avances en el tratamiento de la insuficiencia mitral grave

Translated title of the contribution: Progress in the treatment of severe mitral regurgitation

Hector I Michelena, Valentina M. Bichara, Edit Margaryan, Inga Forde, Yan Topilsky, Rakesh Suri, Maurice E Sarano

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Organic mitral regurgitation (MR) is prevalent in the general population. Disease progression, involving potentially irreversible left ventricular dysfunction, implies a poor prognosis for patients who do not receive appropriate treatment. Immediate rescue surgery is indicated in those with severe MR in whom subclinical left ventricular dysfunction is suggested by echocardiographic measurements or the presence of symptoms, however minor. Patients whose symptomatology is unclear should be evaluated by exercise testing. Not all forms of severe organic MR are the same: the presence of risk factors in patients with severe asymptomatic MR and preserved ventricular function indicates a suboptimal prognosis over the medium-to-long term and should prompt early mitral repair if there is a low surgical risk and the probability of a successful repair is >90-95%. The patient should be referred to a specialized surgical center if necessary. Appropriate training of surgeons in mitral repair is essential. Ischemic MR carries a worse prognosis and the risk of surgery is higher. Consequently, treatment decisions must be patient-specific and take into account the possibility of repair, the risk of surgery, and the need for concomitant surgical revascularization. New percutaneous approaches to mitral repair are being developed for selected patient groups.

Original languageSpanish
Pages (from-to)820-831
Number of pages12
JournalRevista Espanola de Cardiologia
Volume63
Issue number7
DOIs
StatePublished - 2010

Fingerprint

Mitral Valve Insufficiency
Left Ventricular Dysfunction
Therapeutics
Ventricular Function
Disease Progression
Exercise
Population

Keywords

  • Mitral valve
  • Regurgitation
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Avances en el tratamiento de la insuficiencia mitral grave. / Michelena, Hector I; Bichara, Valentina M.; Margaryan, Edit; Forde, Inga; Topilsky, Yan; Suri, Rakesh; Sarano, Maurice E.

In: Revista Espanola de Cardiologia, Vol. 63, No. 7, 2010, p. 820-831.

Research output: Contribution to journalArticle

Michelena, Hector I ; Bichara, Valentina M. ; Margaryan, Edit ; Forde, Inga ; Topilsky, Yan ; Suri, Rakesh ; Sarano, Maurice E. / Avances en el tratamiento de la insuficiencia mitral grave. In: Revista Espanola de Cardiologia. 2010 ; Vol. 63, No. 7. pp. 820-831.
@article{e8174cd2a73049b595eacafc6751a3fb,
title = "Avances en el tratamiento de la insuficiencia mitral grave",
abstract = "Organic mitral regurgitation (MR) is prevalent in the general population. Disease progression, involving potentially irreversible left ventricular dysfunction, implies a poor prognosis for patients who do not receive appropriate treatment. Immediate rescue surgery is indicated in those with severe MR in whom subclinical left ventricular dysfunction is suggested by echocardiographic measurements or the presence of symptoms, however minor. Patients whose symptomatology is unclear should be evaluated by exercise testing. Not all forms of severe organic MR are the same: the presence of risk factors in patients with severe asymptomatic MR and preserved ventricular function indicates a suboptimal prognosis over the medium-to-long term and should prompt early mitral repair if there is a low surgical risk and the probability of a successful repair is >90-95{\%}. The patient should be referred to a specialized surgical center if necessary. Appropriate training of surgeons in mitral repair is essential. Ischemic MR carries a worse prognosis and the risk of surgery is higher. Consequently, treatment decisions must be patient-specific and take into account the possibility of repair, the risk of surgery, and the need for concomitant surgical revascularization. New percutaneous approaches to mitral repair are being developed for selected patient groups.",
keywords = "Mitral valve, Regurgitation, Treatment",
author = "Michelena, {Hector I} and Bichara, {Valentina M.} and Edit Margaryan and Inga Forde and Yan Topilsky and Rakesh Suri and Sarano, {Maurice E}",
year = "2010",
doi = "10.1016/S0300-8932(10)70185-8",
language = "Spanish",
volume = "63",
pages = "820--831",
journal = "Revista Espanola de Cardiologia",
issn = "0300-8932",
publisher = "Ediciones Doyma, S.L.",
number = "7",

}

TY - JOUR

T1 - Avances en el tratamiento de la insuficiencia mitral grave

AU - Michelena, Hector I

AU - Bichara, Valentina M.

AU - Margaryan, Edit

AU - Forde, Inga

AU - Topilsky, Yan

AU - Suri, Rakesh

AU - Sarano, Maurice E

PY - 2010

Y1 - 2010

N2 - Organic mitral regurgitation (MR) is prevalent in the general population. Disease progression, involving potentially irreversible left ventricular dysfunction, implies a poor prognosis for patients who do not receive appropriate treatment. Immediate rescue surgery is indicated in those with severe MR in whom subclinical left ventricular dysfunction is suggested by echocardiographic measurements or the presence of symptoms, however minor. Patients whose symptomatology is unclear should be evaluated by exercise testing. Not all forms of severe organic MR are the same: the presence of risk factors in patients with severe asymptomatic MR and preserved ventricular function indicates a suboptimal prognosis over the medium-to-long term and should prompt early mitral repair if there is a low surgical risk and the probability of a successful repair is >90-95%. The patient should be referred to a specialized surgical center if necessary. Appropriate training of surgeons in mitral repair is essential. Ischemic MR carries a worse prognosis and the risk of surgery is higher. Consequently, treatment decisions must be patient-specific and take into account the possibility of repair, the risk of surgery, and the need for concomitant surgical revascularization. New percutaneous approaches to mitral repair are being developed for selected patient groups.

AB - Organic mitral regurgitation (MR) is prevalent in the general population. Disease progression, involving potentially irreversible left ventricular dysfunction, implies a poor prognosis for patients who do not receive appropriate treatment. Immediate rescue surgery is indicated in those with severe MR in whom subclinical left ventricular dysfunction is suggested by echocardiographic measurements or the presence of symptoms, however minor. Patients whose symptomatology is unclear should be evaluated by exercise testing. Not all forms of severe organic MR are the same: the presence of risk factors in patients with severe asymptomatic MR and preserved ventricular function indicates a suboptimal prognosis over the medium-to-long term and should prompt early mitral repair if there is a low surgical risk and the probability of a successful repair is >90-95%. The patient should be referred to a specialized surgical center if necessary. Appropriate training of surgeons in mitral repair is essential. Ischemic MR carries a worse prognosis and the risk of surgery is higher. Consequently, treatment decisions must be patient-specific and take into account the possibility of repair, the risk of surgery, and the need for concomitant surgical revascularization. New percutaneous approaches to mitral repair are being developed for selected patient groups.

KW - Mitral valve

KW - Regurgitation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=77955036303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955036303&partnerID=8YFLogxK

U2 - 10.1016/S0300-8932(10)70185-8

DO - 10.1016/S0300-8932(10)70185-8

M3 - Article

C2 - 20609316

AN - SCOPUS:77955036303

VL - 63

SP - 820

EP - 831

JO - Revista Espanola de Cardiologia

JF - Revista Espanola de Cardiologia

SN - 0300-8932

IS - 7

ER -